Fantastic visit of ⁦Danielle Carnival⁩ from ⁦The White House⁩ to ⁦Huntsman Cancer Institute⁩ - great discussions on ⬆️ access & partnerships across the #MountainWest ! #CancerMoonshot ⁦Theresa L Werner MD⁩ ⁦Neeraj Agarwal, MD, FASCO⁩ ⁦Alana Welm⁩ ⁦HCI Community Outreach and Engagement⁩

Join us for the #ResearchToPractice Research To Practice #ProstateCancer program on June 1st, Saturday evening, during #ASCO24 ASCO 👉Registration link👉 t.ly/xQ1Hf Emmanuel Antonarakis Andrew Armstrong Tanya Dorff ZERO Prostate Cancer OncoAlert

The OncoAlert🚨NEWSLETTER OUT
Covering May 17-23 , 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Discussing:
✅ICI’s 💉for POLE or POLD1 in met CRC
✅Advancements in mgt of Synchronous CRC Liver Mets
✅5yr outcome w/pembro💉 mono NSCLC🫁
✅SBRT☢️ in Lung

Honored to be part of ASCO Guideline Panel for selection of germline genetic testing panels in patients with cancer. Provides direct, comprehensible guidance for oncologists and other health practitioners. bit.ly/4av5utJ Journal of Clinical Oncology ASCO OncoAlert

I had the honor of giving two commencement addresses last week, at ColumbiaPublicHealth & at my alma mater Spencer Fox Eccles School of Medicine. I have great confidence in the graduates as they embrace the challenging, rewarding paths of public health and medicine. Congratulations again!

Register now for our upcoming roundtable, mCRPC: Best practice and new insights, on *19 June 2024, 15.00 - 16.00 UTC*

ow.ly/N1p650ROApS

Not available for those based in the United States Axel S. Merseburger Bárbara Melão Neeraj Agarwal, MD, FASCO

So appreciative of ⁦Dr. Monica M. Bertagnolli⁩, who engaged in forward-looking discussions with us ⁦Huntsman Cancer Institute⁩ on #AI , #access for #rural populations & more - & concluded with a panel on a #Sundance film on a #NativeAmerican student ⁦Michael L. Good, MD⁩ ⁦Gita Suneja MD MS⁩

A video on youtube as a part of my interview on importance of Clinical Trials. Can be useful to motivate patients and letting them take informed decisions.
youtu.be/CVSsp95kyDc

Tata Memorial Centre, Varanasi (MPMMCC & HBCH) ACTREC-TMC Dr. Pankaj Chaturvedi Neeraj Agarwal, MD, FASCO IASLC ESMO - Eur. Oncology The ASCO Post

💫🌟Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The #EMBARK Trial

📚 Authors: David Einstein, Meredith Regan, ScD, Julia S. Stevens, David F. @McDermott, Ravi A Madan M.D..
OncoAlert
🔍 Key findings
🔬 PSA detects micrometastatic

Interested in reading the protocol?
pubmed.ncbi.nlm.nih.gov/37208232/
Interested in the early results?
Coming soon at a conference near you!
#BladderCancerAwarenessMonth 🧡
Fight Bladder Cancer Bladder Cancer Advocacy Network Ashish M. Kamat, MD, MBBS Shilpa Gupta Neeraj Agarwal, MD, FASCO Valérie Fonteyne

Proud of Regina Barragan-Carrillo City of Hope for her terrific poster at the AACR #bladdercancer meeting! A rising star in the field, no doubt. Dr. Bishoy M. Faltas Vivek Subbiah, MD Toni Choueiri, MD Matt Galsky Jonathan Rosenberg MD Rana McKay Tian Zhang, MD, MHS Neeraj Agarwal, MD, FASCO Petros Grivas

📑✍️A must-read editorial about the intermediaye endpoints in patients with non-metastatic #prostate #cancer ‼️

Highly recommended for sunday reading🌻🏖️

doi.org/10.1016/j.euru…

OncoAlert European Urology European Association of Urology (EAU) Sabine D. Brookman-May Advanced Prostate Cancer Consensus Conference

Just in Kidney Cancer👉Interesting systematic review by #AlfredoDistante Stijn Muselaers on pt selection for active surveillance of small renal masses #kidneycancer 👉Age, cardiovascular index & CKD were associated with⬇️OS👇
tinyurl.com/2ty3dna5 OncoAlert UroToday.com KidneyCAN

Does oncologic treatment for very advanced disease improve survival?
1⃣The study analyzed 78,446 adult patients with six common metastatic solid tumors. It found no significant survival benefit for patients receiving more systemic therapy for very advanced cancer.
2⃣There was no

Deeply honored to be nominated to serve on the ASCO GU Cancer Guideline Advisory Group! Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Scott Tagawa Petros Grivas Andrea Necchi Jame Abraham, MD, FACP Toni Choueiri, MD Andrea Apolo, M.D. Elizabeth Plimack MD Ashish M. Kamat, MD, MBBS Alok Khorana, MD Nathan A. Pennell MD, PhD, FASCO Cleveland Clinic MD Brian Rini, MD Manmeet Ahluwalia, MD, MBA, FASCO

Wonderful, insightful visit by ⁦Dr. Monica M. Bertagnolli⁩ to ⁦Huntsman Cancer Institute⁩ and ⁦University of Utah⁩! Great discussions on AI, #BenchToBedside , access & #rural cancer care! ⁦Alana Welm⁩ ⁦Theresa L Werner MD⁩ ⁦HCI Community Outreach and Engagement⁩ #WomenInMedicine #woneninStwm

Huge thanks to Shahla Bari for the invitation to Duke Cancer to discuss the #microbiome in #kidneycancer . I'll be highlighting work from my terrific team (@NazliDizman Hedyeh Ebrahimi Regina Barragan-Carrillo @luismezaco et al) & also some of the pioneering studies led by Bertrand Routy MD,PhD

Why are we smiling😁? Because we like our jobs in academia and got invited to speak about it at the place to be during #ASCO24 : The ASCO TECAG Trainee Lounge

Join us for this Panel Discussion on Careers in Oncology Academia with Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute Amanda Nizam, MD

Just in Kidney Cancer 👉Excellent review by Albert Jang, MD @ShilpaOnc on papillary RCC #kidneycancer 👉Despite improved outcomes with VEGF-TKIs and ICIs, more dedicated clinical trials to pRCC are urgently needed👇
tinyurl.com/4cpsha2p UroToday.com OncoAlert KidneyCAN Kidney Cancer

Ray Manneh Kopp Martín Angel GUARD Consortium AstraZeneca I’m incredibly proud to be involved in amazing work of Ray Manneh Kopp Pedro Isaacsson and many other stellar GU oncologists & AstraZeneca for this effort in standardizing genetic testing in prostate cancer in #LATAM 👏 important findings and further studies ongoing! JCO Precision Oncology